0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Convalescent Plasma Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-0A14382
Home | Market Reports | Health| Nursing
Global Convalescent Plasma Therapy Market Research Report 2023
BUY CHAPTERS

Convalescent Plasma Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-0A14382
Report
November 2024
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Convalescent Plasma Therapy - Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Convalescent Plasma Therapy - Market

Convalescent Plasma Therapy - Market

Convalescent plasma is the plasma collected from the recovered or convalesced people consisting of the antibodies against the infection causing microorganism.
The global market for Convalescent Plasma Therapy was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Convalescent Plasma Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Convalescent Plasma Therapy by region & country, by Type, and by Application.
The Convalescent Plasma Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Convalescent Plasma Therapy.
Market Segmentation

Scope of Convalescent Plasma Therapy - Market Report

Report Metric Details
Report Name Convalescent Plasma Therapy - Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type:
  • IgM
  • IgG
  • IgA
Segment by Application
  • Prophylaxis
  • Treatment
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bio Farma, Grifols, Hilton Pharma, Biotest, BPL, LFB, Octapharma, CSL Behring, Takeda Pharmaceutical Company Limited, Orthosera Kft
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Convalescent Plasma Therapy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Convalescent Plasma Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Convalescent Plasma Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Convalescent Plasma Therapy - Market report?

Ans: The main players in the Convalescent Plasma Therapy - Market are Bio Farma, Grifols, Hilton Pharma, Biotest, BPL, LFB, Octapharma, CSL Behring, Takeda Pharmaceutical Company Limited, Orthosera Kft

What are the Application segmentation covered in the Convalescent Plasma Therapy - Market report?

Ans: The Applications covered in the Convalescent Plasma Therapy - Market report are Prophylaxis, Treatment

What are the Type segmentation covered in the Convalescent Plasma Therapy - Market report?

Ans: The Types covered in the Convalescent Plasma Therapy - Market report are IgM, IgG, IgA

1 Market Overview
1.1 Convalescent Plasma Therapy Product Introduction
1.2 Global Convalescent Plasma Therapy Market Size Forecast
1.3 Convalescent Plasma Therapy Market Trends & Drivers
1.3.1 Convalescent Plasma Therapy Industry Trends
1.3.2 Convalescent Plasma Therapy Market Drivers & Opportunity
1.3.3 Convalescent Plasma Therapy Market Challenges
1.3.4 Convalescent Plasma Therapy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Convalescent Plasma Therapy Players Revenue Ranking (2023)
2.2 Global Convalescent Plasma Therapy Revenue by Company (2019-2024)
2.3 Key Companies Convalescent Plasma Therapy Manufacturing Base Distribution and Headquarters
2.4 Key Companies Convalescent Plasma Therapy Product Offered
2.5 Key Companies Time to Begin Mass Production of Convalescent Plasma Therapy
2.6 Convalescent Plasma Therapy Market Competitive Analysis
2.6.1 Convalescent Plasma Therapy Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Convalescent Plasma Therapy Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Convalescent Plasma Therapy as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 IgM
3.1.2 IgG
3.1.3 IgA
3.2 Global Convalescent Plasma Therapy Sales Value by Type
3.2.1 Global Convalescent Plasma Therapy Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Convalescent Plasma Therapy Sales Value, by Type (2019-2030)
3.2.3 Global Convalescent Plasma Therapy Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Prophylaxis
4.1.2 Treatment
4.2 Global Convalescent Plasma Therapy Sales Value by Application
4.2.1 Global Convalescent Plasma Therapy Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Convalescent Plasma Therapy Sales Value, by Application (2019-2030)
4.2.3 Global Convalescent Plasma Therapy Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Convalescent Plasma Therapy Sales Value by Region
5.1.1 Global Convalescent Plasma Therapy Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Convalescent Plasma Therapy Sales Value by Region (2019-2024)
5.1.3 Global Convalescent Plasma Therapy Sales Value by Region (2025-2030)
5.1.4 Global Convalescent Plasma Therapy Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Convalescent Plasma Therapy Sales Value, 2019-2030
5.2.2 North America Convalescent Plasma Therapy Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Convalescent Plasma Therapy Sales Value, 2019-2030
5.3.2 Europe Convalescent Plasma Therapy Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Convalescent Plasma Therapy Sales Value, 2019-2030
5.4.2 Asia Pacific Convalescent Plasma Therapy Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Convalescent Plasma Therapy Sales Value, 2019-2030
5.5.2 South America Convalescent Plasma Therapy Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Convalescent Plasma Therapy Sales Value, 2019-2030
5.6.2 Middle East & Africa Convalescent Plasma Therapy Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Convalescent Plasma Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Convalescent Plasma Therapy Sales Value
6.3 United States
6.3.1 United States Convalescent Plasma Therapy Sales Value, 2019-2030
6.3.2 United States Convalescent Plasma Therapy Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Convalescent Plasma Therapy Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Convalescent Plasma Therapy Sales Value, 2019-2030
6.4.2 Europe Convalescent Plasma Therapy Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Convalescent Plasma Therapy Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Convalescent Plasma Therapy Sales Value, 2019-2030
6.5.2 China Convalescent Plasma Therapy Sales Value by Type (%), 2023 VS 2030
6.5.3 China Convalescent Plasma Therapy Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Convalescent Plasma Therapy Sales Value, 2019-2030
6.6.2 Japan Convalescent Plasma Therapy Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Convalescent Plasma Therapy Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Convalescent Plasma Therapy Sales Value, 2019-2030
6.7.2 South Korea Convalescent Plasma Therapy Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Convalescent Plasma Therapy Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Convalescent Plasma Therapy Sales Value, 2019-2030
6.8.2 Southeast Asia Convalescent Plasma Therapy Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Convalescent Plasma Therapy Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Convalescent Plasma Therapy Sales Value, 2019-2030
6.9.2 India Convalescent Plasma Therapy Sales Value by Type (%), 2023 VS 2030
6.9.3 India Convalescent Plasma Therapy Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bio Farma
7.1.1 Bio Farma Profile
7.1.2 Bio Farma Main Business
7.1.3 Bio Farma Convalescent Plasma Therapy Products, Services and Solutions
7.1.4 Bio Farma Convalescent Plasma Therapy Revenue (US$ Million) & (2019-2024)
7.1.5 Bio Farma Recent Developments
7.2 Grifols
7.2.1 Grifols Profile
7.2.2 Grifols Main Business
7.2.3 Grifols Convalescent Plasma Therapy Products, Services and Solutions
7.2.4 Grifols Convalescent Plasma Therapy Revenue (US$ Million) & (2019-2024)
7.2.5 Grifols Recent Developments
7.3 Hilton Pharma
7.3.1 Hilton Pharma Profile
7.3.2 Hilton Pharma Main Business
7.3.3 Hilton Pharma Convalescent Plasma Therapy Products, Services and Solutions
7.3.4 Hilton Pharma Convalescent Plasma Therapy Revenue (US$ Million) & (2019-2024)
7.3.5 Biotest Recent Developments
7.4 Biotest
7.4.1 Biotest Profile
7.4.2 Biotest Main Business
7.4.3 Biotest Convalescent Plasma Therapy Products, Services and Solutions
7.4.4 Biotest Convalescent Plasma Therapy Revenue (US$ Million) & (2019-2024)
7.4.5 Biotest Recent Developments
7.5 BPL
7.5.1 BPL Profile
7.5.2 BPL Main Business
7.5.3 BPL Convalescent Plasma Therapy Products, Services and Solutions
7.5.4 BPL Convalescent Plasma Therapy Revenue (US$ Million) & (2019-2024)
7.5.5 BPL Recent Developments
7.6 LFB
7.6.1 LFB Profile
7.6.2 LFB Main Business
7.6.3 LFB Convalescent Plasma Therapy Products, Services and Solutions
7.6.4 LFB Convalescent Plasma Therapy Revenue (US$ Million) & (2019-2024)
7.6.5 LFB Recent Developments
7.7 Octapharma
7.7.1 Octapharma Profile
7.7.2 Octapharma Main Business
7.7.3 Octapharma Convalescent Plasma Therapy Products, Services and Solutions
7.7.4 Octapharma Convalescent Plasma Therapy Revenue (US$ Million) & (2019-2024)
7.7.5 Octapharma Recent Developments
7.8 CSL Behring
7.8.1 CSL Behring Profile
7.8.2 CSL Behring Main Business
7.8.3 CSL Behring Convalescent Plasma Therapy Products, Services and Solutions
7.8.4 CSL Behring Convalescent Plasma Therapy Revenue (US$ Million) & (2019-2024)
7.8.5 CSL Behring Recent Developments
7.9 Takeda Pharmaceutical Company Limited
7.9.1 Takeda Pharmaceutical Company Limited Profile
7.9.2 Takeda Pharmaceutical Company Limited Main Business
7.9.3 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Products, Services and Solutions
7.9.4 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Revenue (US$ Million) & (2019-2024)
7.9.5 Takeda Pharmaceutical Company Limited Recent Developments
7.10 Orthosera Kft
7.10.1 Orthosera Kft Profile
7.10.2 Orthosera Kft Main Business
7.10.3 Orthosera Kft Convalescent Plasma Therapy Products, Services and Solutions
7.10.4 Orthosera Kft Convalescent Plasma Therapy Revenue (US$ Million) & (2019-2024)
7.10.5 Orthosera Kft Recent Developments
8 Industry Chain Analysis
8.1 Convalescent Plasma Therapy Industrial Chain
8.2 Convalescent Plasma Therapy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Convalescent Plasma Therapy Sales Model
8.5.2 Sales Channel
8.5.3 Convalescent Plasma Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Convalescent Plasma Therapy Market Trends
    Table 2. Convalescent Plasma Therapy Market Drivers & Opportunity
    Table 3. Convalescent Plasma Therapy Market Challenges
    Table 4. Convalescent Plasma Therapy Market Restraints
    Table 5. Global Convalescent Plasma Therapy Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Convalescent Plasma Therapy Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Convalescent Plasma Therapy Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Convalescent Plasma Therapy Product Type
    Table 9. Key Companies Time to Begin Mass Production of Convalescent Plasma Therapy
    Table 10. Global Convalescent Plasma Therapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Convalescent Plasma Therapy as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Convalescent Plasma Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Convalescent Plasma Therapy Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Convalescent Plasma Therapy Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Convalescent Plasma Therapy Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Convalescent Plasma Therapy Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Convalescent Plasma Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Convalescent Plasma Therapy Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Convalescent Plasma Therapy Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Convalescent Plasma Therapy Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Convalescent Plasma Therapy Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Convalescent Plasma Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Convalescent Plasma Therapy Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Convalescent Plasma Therapy Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Convalescent Plasma Therapy Sales Value by Region (2019-2024) & (%)
    Table 27. Global Convalescent Plasma Therapy Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Convalescent Plasma Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Convalescent Plasma Therapy Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Convalescent Plasma Therapy Sales Value, (2025-2030) & (US$ Million)
    Table 31. Bio Farma Basic Information List
    Table 32. Bio Farma Description and Business Overview
    Table 33. Bio Farma Convalescent Plasma Therapy Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Convalescent Plasma Therapy Business of Bio Farma (2019-2024)
    Table 35. Bio Farma Recent Developments
    Table 36. Grifols Basic Information List
    Table 37. Grifols Description and Business Overview
    Table 38. Grifols Convalescent Plasma Therapy Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Convalescent Plasma Therapy Business of Grifols (2019-2024)
    Table 40. Grifols Recent Developments
    Table 41. Hilton Pharma Basic Information List
    Table 42. Hilton Pharma Description and Business Overview
    Table 43. Hilton Pharma Convalescent Plasma Therapy Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Convalescent Plasma Therapy Business of Hilton Pharma (2019-2024)
    Table 45. Hilton Pharma Recent Developments
    Table 46. Biotest Basic Information List
    Table 47. Biotest Description and Business Overview
    Table 48. Biotest Convalescent Plasma Therapy Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Convalescent Plasma Therapy Business of Biotest (2019-2024)
    Table 50. Biotest Recent Developments
    Table 51. BPL Basic Information List
    Table 52. BPL Description and Business Overview
    Table 53. BPL Convalescent Plasma Therapy Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Convalescent Plasma Therapy Business of BPL (2019-2024)
    Table 55. BPL Recent Developments
    Table 56. LFB Basic Information List
    Table 57. LFB Description and Business Overview
    Table 58. LFB Convalescent Plasma Therapy Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Convalescent Plasma Therapy Business of LFB (2019-2024)
    Table 60. LFB Recent Developments
    Table 61. Octapharma Basic Information List
    Table 62. Octapharma Description and Business Overview
    Table 63. Octapharma Convalescent Plasma Therapy Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Convalescent Plasma Therapy Business of Octapharma (2019-2024)
    Table 65. Octapharma Recent Developments
    Table 66. CSL Behring Basic Information List
    Table 67. CSL Behring Description and Business Overview
    Table 68. CSL Behring Convalescent Plasma Therapy Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Convalescent Plasma Therapy Business of CSL Behring (2019-2024)
    Table 70. CSL Behring Recent Developments
    Table 71. Takeda Pharmaceutical Company Limited Basic Information List
    Table 72. Takeda Pharmaceutical Company Limited Description and Business Overview
    Table 73. Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Convalescent Plasma Therapy Business of Takeda Pharmaceutical Company Limited (2019-2024)
    Table 75. Takeda Pharmaceutical Company Limited Recent Developments
    Table 76. Orthosera Kft Basic Information List
    Table 77. Orthosera Kft Description and Business Overview
    Table 78. Orthosera Kft Convalescent Plasma Therapy Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Convalescent Plasma Therapy Business of Orthosera Kft (2019-2024)
    Table 80. Orthosera Kft Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Convalescent Plasma Therapy Downstream Customers
    Table 84. Convalescent Plasma Therapy Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Convalescent Plasma Therapy Product Picture
    Figure 2. Global Convalescent Plasma Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Convalescent Plasma Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 4. Convalescent Plasma Therapy Report Years Considered
    Figure 5. Global Convalescent Plasma Therapy Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Convalescent Plasma Therapy Revenue in 2023
    Figure 7. Convalescent Plasma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. IgM Picture
    Figure 9. IgG Picture
    Figure 10. IgA Picture
    Figure 11. Global Convalescent Plasma Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Convalescent Plasma Therapy Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Prophylaxis
    Figure 14. Product Picture of Treatment
    Figure 15. Global Convalescent Plasma Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Convalescent Plasma Therapy Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Convalescent Plasma Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Convalescent Plasma Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Convalescent Plasma Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Convalescent Plasma Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Convalescent Plasma Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Convalescent Plasma Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Convalescent Plasma Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Convalescent Plasma Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Convalescent Plasma Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Convalescent Plasma Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Convalescent Plasma Therapy Sales Value (%), (2019-2030)
    Figure 28. United States Convalescent Plasma Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Convalescent Plasma Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Convalescent Plasma Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Convalescent Plasma Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Convalescent Plasma Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Convalescent Plasma Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Convalescent Plasma Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Convalescent Plasma Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Convalescent Plasma Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Convalescent Plasma Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Convalescent Plasma Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Convalescent Plasma Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Convalescent Plasma Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Convalescent Plasma Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Convalescent Plasma Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Convalescent Plasma Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Convalescent Plasma Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Convalescent Plasma Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Convalescent Plasma Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Convalescent Plasma Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Convalescent Plasma Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 49. Convalescent Plasma Therapy Industrial Chain
    Figure 50. Convalescent Plasma Therapy Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Ophthalmic Image Management System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-38G14483
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Intelligent Nursing Bed Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-30I18367
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Quinolones Analysis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-3Q14968
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Sodium Iodide [131I] Oral Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-1N15124
Thu Dec 12 00:00:00 UTC 2024

Add to Cart